Synergy Asset Management LLC Sells 4,181 Shares of Sanofi (NASDAQ:SNY)

Synergy Asset Management LLC cut its stake in shares of Sanofi (NASDAQ:SNY) by 6.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 56,528 shares of the company’s stock after selling 4,181 shares during the period. Synergy Asset Management LLC’s holdings in Sanofi were worth $2,747,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently bought and sold shares of SNY. Armistice Capital LLC purchased a new position in Sanofi during the 4th quarter valued at about $51,520,000. Morningstar Investment Services LLC raised its position in shares of Sanofi by 99.5% in the 4th quarter. Morningstar Investment Services LLC now owns 1,486,949 shares of the company’s stock worth $73,425,000 after acquiring an additional 741,456 shares in the last quarter. Brandes Investment Partners LP lifted its stake in shares of Sanofi by 64.6% during the 4th quarter. Brandes Investment Partners LP now owns 1,770,572 shares of the company’s stock worth $88,051,000 after purchasing an additional 694,957 shares during the last quarter. Iron Triangle Partners LP purchased a new position in Sanofi in the fourth quarter valued at about $24,865,000. Finally, Morgan Stanley lifted its position in shares of Sanofi by 4.6% during the third quarter. Morgan Stanley now owns 7,322,806 shares of the company’s stock valued at $392,796,000 after buying an additional 323,968 shares during the last quarter. Hedge funds and other institutional investors own 10.04% of the company’s stock.

Sanofi Stock Down 1.8 %

Shares of Sanofi stock traded down $0.87 on Tuesday, reaching $48.72. The stock had a trading volume of 1,893,591 shares, compared to its average volume of 2,117,590. The company has a quick ratio of 0.87, a current ratio of 1.27 and a debt-to-equity ratio of 0.19. The stock has a market capitalization of $123.39 billion, a P/E ratio of 24.48, a P/E/G ratio of 1.50 and a beta of 0.59. The company has a 50 day moving average price of $48.68 and a 200 day moving average price of $48.57. Sanofi has a 1 year low of $42.63 and a 1 year high of $55.72.

Sanofi (NASDAQ:SNY) last issued its quarterly earnings results on Thursday, April 25th. The company reported $0.96 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.96. Sanofi had a return on equity of 26.25% and a net margin of 10.52%. The business had revenue of $11.36 billion for the quarter, compared to the consensus estimate of $11.75 billion. As a group, equities research analysts forecast that Sanofi will post 4.13 EPS for the current year.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.